4-STEP-Training Program for Doomscrolling, Cyberchondriac Behavior and Psychiatric Symptoms (4-STEP-TPS) Among Individuals With Social Media Addiction ((4-STEP-TPS))
Effectiveness of 4-Step Training Program for Doomscrolling, Cyberchondriac Behavior and Psychiatric Symptoms Among Individuals With Social Media Addiction: A Randomized Trial
調査の概要
状態
詳細な説明
In this research, a sample of approximately N = 300 young adults will be initially enrolled for eligibility screening from public and private universities in Faisalabad and Sahiwal, Pakistan, using purposive sampling techniques. Participants will be aged between 18 and 28 years and will have no history of severe physical, psychiatric, or psychological disorders. After eligibility assessment and screening based on standardized measures, N = 80 participants will be selected and randomly allocated to the experimental and waitlist control groups.
This study is expected to provide valuable evidence for mental health practitioners regarding effective interventions for managing social media addiction among young adults. The 4-STEP Training Program is anticipated to enhance participants' awareness and understanding of problematic digital behaviors, including doomscrolling and cyberchondriac behavior. The intervention is also expected to reduce depressive symptoms and health anxiety, improve self-regulation and promote healthier digital habits. Furthermore, the program is expected to enhance psychological well-being, academic functioning, and overall productivity while significantly reducing levels of social media addiction.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Qasir Abbas, PhD Clinical Psychology
- 電話番号:923337683133
- メール:qasirabbas47@yahoo.com
研究連絡先のバックアップ
- 名前:Atika Shafi, MS Clinical Psychology
研究場所
-
-
Punjab Province
-
Faisalabad、Punjab Province、パキスタン、38000
- Government College University Faisalabad
-
コンタクト:
- Qasir Abbas, PhD Clinical Psychology
- 電話番号:923337683133
- メール:qasirabbas47@yahoo.com
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Age range: 18-29 years
- No physical, psychiatric, or psychological conditions
- Minimum score of 84 on the Social Networking Addiction Scale (SNAS)
- Minimum score of 23 on the Cyberchondria Severity Scale (CSS-12)
Exclusion Criteria:
- Age below 18 or above 29 years
- Presence of any physical, psychiatric, or psychological conditions
- Score below 84 on the Social Networking Addiction Scale (SNAS)
- Score below 23 on the Cyberchondria Severity Scale (CSS-12)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:対照群
介入なし
|
|
|
実験的:実験グループ:個別設定
1-1設定の4STEPトレーニングプログラム
|
4 Modules with 1 Module being delivered in 1 weekly session of approximately 90 minutes.
The details of each module/step is described as follows: Step 1 (Module 1): S = Screening, Assessment and Psychoeducation: Involves screening and assessment of the problem, interpretation of the results, feedback and psychoeducation, identifying and breaking the resistance, motivation, and conceptualization.
Step 2 (Module 2): T = Treatment Conceptualization and Planning: Involves pattern identification, distortion identification, as well as pattern and distortions modifications.
Step 3 (Module 3): E = Effective Management Strategies: Involves management strategies to treat the earlier identified patterns as well as the implementation and confirmation of activities via a Pattern Schedule Chart.
Step 4 (Module 4): P = Prevention (Lapse-Relapse): Involves self-reflection and support building, monitoring and dependency check and slip plans and support additions
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
ソーシャル ネットワーキング依存症スケール (SNAS)
時間枠:スクリーニング時、4 週間後、再評価は最大 6 か月後
|
ソーシャル ネットワーキング依存症スケール (SNAS) は、あらゆる形態のソーシャル ネットワーキングの依存症を 6 次元の顕著性 (項目 1 ~ 4)、気分修正 (項目 5 ~ 7)、耐性 (項目 8 ~ 10)、離脱 (項目 11-14)、紛争 (項目 15-17)、再発 (項目 18-21) (Shahnawaz & Rehman、2020)。
SNAS は自己申告尺度であり、1 (まったく同意しない) から 7 (強く同意する) までの 7 点リッカート尺度で評価される 21 項目の尺度を必要とします。
スコアの範囲は 21 ~ 147 です。
合計スコア 84 を超えるスコアは依存症を意味します。
Shahnawaz と Rehman (2020) によって報告されているように、このスケールは 0.88 という良好なテスト再テストの信頼性と良好な妥当性を実証しています。
|
スクリーニング時、4 週間後、再評価は最大 6 か月後
|
|
Cyberchondria Severity Scale (CSS-12)
時間枠:At screening, after 4 weeks, and reassessment up to 6 months
|
The Cyberchondria Severity Scale-12 (CSS-12), developed by Eoin McElroy et al. (2019), is a 12-item self-report measure assessing excessive, anxiety-provoking online health searches across four dimensions: compulsion, distress, excessiveness, and reassurance-seeking.
Items are rated on a 5-point Likert scale (1 = Never to 5 = Always), with total scores ranging from 12-60; higher scores indicate greater cyberchondria.
The scale is brief, reliable, and valid, suitable for both clinical and non-clinical populations, and widely used to evaluate problematic health-related online behavior.
|
At screening, after 4 weeks, and reassessment up to 6 months
|
|
Doomscrolling Scale (DS)
時間枠:At screening, after 4 weeks, and reassessment up to 6 months
|
The Doomscrolling Scale was developed to assess compulsive engagement with negative online news content and excessive scrolling behavior, particularly during times of crisis (Sharma et al., 2022).
The scale measures three core dimensions: obsessive news consumption, emotional distress, and behavioral compulsion.
It is a self-report instrument consisting of 15 items rated on a 5-point Likert scale ranging from 1 (never) to 5 (always).
The total score is calculated by summing all item responses, with higher scores indicating greater levels of doomscrolling behavior.
The scale has demonstrated good internal consistency (Cronbach's α = 0.88) and satisfactory construct validity (Sharma et al., 2022).
|
At screening, after 4 weeks, and reassessment up to 6 months
|
|
Short Health Anxiety Inventory (SHAI)
時間枠:At screening, after 4 weeks, and reassessment up to 6 months
|
The Short Health Anxiety Inventory (SHAI) was developed to assess health-related anxiety and preoccupation with physical symptoms, independent of actual medical status (Salkovskis et al., 2002).
The scale measures two main dimensions: perceived likelihood of illness and perceived negative consequences of illness.
It is a self-report instrument consisting of 18 items, each presenting four response options scored from 0 to 3, reflecting increasing levels of health anxiety.
Total scores range from 0 to 54, with higher scores indicating greater levels of health anxiety.
The SHAI has demonstrated excellent internal consistency, with reported Cronbach's alpha values ranging from 0.86 to 0.95, and strong convergent and construct validity.
The HAI is a reliable and valid measure of health anxiety (Salkovskis et al., 2002).
|
At screening, after 4 weeks, and reassessment up to 6 months
|
|
Patient Health Questionnaire-9 (PHQ-9)
時間枠:At screening, after 4 weeks, and reassessment up to 6 months
|
The Patient Health Questionnaire-9 (PHQ-9) was developed to measure the severity of depressive symptoms based on the diagnostic criteria of major depressive disorder (Kroenke et al., 2001).
The scale assesses nine core symptoms of depression, including low mood, loss of interest, fatigue, sleep disturbances, appetite changes, concentration difficulties, feelings of worthlessness, psychomotor changes, and suicidal ideation.
The PHQ-9 is a self-report instrument consisting of 9 items rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day).
Total scores range from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders(The PHQ-9 - Kroenke - 2001 - Journal of General Internal Medicine - Wiley Online Library, 2001).
|
At screening, after 4 weeks, and reassessment up to 6 months
|
協力者と研究者
捜査官
- 主任研究者:Qasir Abbas, PhD Clinical Psychology、Government College University Faisalabad
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- GCUF_CT_STP
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。